Cargando…

Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)

Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Venable, Sateria R., Al-Hendy, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499739/
https://www.ncbi.nlm.nih.gov/pubmed/37568061
http://dx.doi.org/10.1007/s12325-023-02595-x
_version_ 1785105772209766400
author Venable, Sateria R.
Al-Hendy, Ayman
author_facet Venable, Sateria R.
Al-Hendy, Ayman
author_sort Venable, Sateria R.
collection PubMed
description Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12325-023-02595-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-10499739
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-104997392023-09-15 Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) Venable, Sateria R. Al-Hendy, Ayman Adv Ther Commentary Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12325-023-02595-x) contains supplementary material, which is available to authorized users. Springer Healthcare 2023-08-12 2023 /pmc/articles/PMC10499739/ /pubmed/37568061 http://dx.doi.org/10.1007/s12325-023-02595-x Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Commentary
Venable, Sateria R.
Al-Hendy, Ayman
Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
title Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
title_full Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
title_fullStr Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
title_full_unstemmed Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
title_short Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
title_sort uterine fibroids: a podcast on patient and physician perspectives on medical management and a new medical therapy (relugolix combination therapy)
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499739/
https://www.ncbi.nlm.nih.gov/pubmed/37568061
http://dx.doi.org/10.1007/s12325-023-02595-x
work_keys_str_mv AT venablesateriar uterinefibroidsapodcastonpatientandphysicianperspectivesonmedicalmanagementandanewmedicaltherapyrelugolixcombinationtherapy
AT alhendyayman uterinefibroidsapodcastonpatientandphysicianperspectivesonmedicalmanagementandanewmedicaltherapyrelugolixcombinationtherapy